Fenbendazole is an anthelmintic medication that has been used for decades to treat parasites. It has also shown some effectiveness against cancer in animal studies. But there’s a lot of skepticism about whether fenbendazole will work in humans.
The so-called Joe Tippens Cancer Protocol gained popularity in the past year after an anecdotal story about a terminal cancer patient who claimed to have reversed his disease by taking fenbendazole. The medication, which is sold as Panacur C and is also an ingredient in dog wormers, is believed to help fight cancer by interfering with the formation of microtubules. Microtubules are a protein scaffolding that gives cells their shape and structure.
Researchers have shown that fenbendazole and other benzimidazole drugs inhibit the growth of a wide range of cancer cell lines in laboratory experiments. These drugs also reactivate the p53 gene in tumor cells, which normally functions as a tumor suppressor.
However, no studies of fenbendazole for humans cancer have been published. And even if the drug were to work in people, it’s unclear how safe and effective it would be.
A small number of cancer patients report a successful response to fenbendazole, a drug commonly known as “Panacur.” To find out more about how people get this information, the researchers conducted semi-structured interviews with cancer patients who had taken the drug. Some of the patients attributed their knowledge about fenbendazole to friends, acquaintances, or family members (B, J, L, P, and S). Others reported hearing about it on TV or from the Internet. fenbendazole for humans cancer